Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Nucl Med. 2006 Dec;31(12):790-1.

Low-dose P32 therapy in essential thrombocythemia.

Author information

  • 1Department of Radiology, Yale New Haven Hospital, New Haven, Connecticut 06510, USA. Neetha.Shetty-Alva@yale.edu

Abstract

We present a case of an 85-year-old woman with medically refractory essential thrombocythemia and subsequent venous thrombosis. She received conservative phosphorus-32 sodium phosphate therapy for 3 mCi, approximately half the usual dose. One month later, she received a second intravenous phosphorus-32 treatment of 3.5 mCi. She responded successfully to both treatments with drops in her platelet count and experienced no adverse effects. Our case is noteworthy in the effectiveness from a conservative dose while avoiding hematologic complications.

PMID:
17117074
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk